{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:27:15Z","timestamp":1784694435255,"version":"3.55.0"},"reference-count":16,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.25-0619","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:10:17Z","timestamp":1771539017000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Poorly Differentiated Lower Esophageal Cancer with Neuroendocrine Differentiation and \u03b1-Fetoprotein Production"],"prefix":"10.70352","volume":"12","author":[{"given":"Mamiko","family":"Takii","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Inazu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Minami Osaka Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kimura Y, Okamura A, Takeuchi M, et al. Comprehensive registry of esophageal cancer in Japan,2016. Esophagus 2025; 22: 475\u2013505.","DOI":"10.1007\/s10388-025-01141-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wang X, Wang Q. Alpha-fetoprotein and hepatocellular carcinoma immunity. Can J Gastroenterol Hepatol 2018; 2018: 049252.","DOI":"10.1155\/2018\/9049252"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 2018; 31: 1770\u201386.","DOI":"10.1038\/s41379-018-0110-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Li T, Liu T, Wang M, et al. A-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation a case report. Medicine (Baltimore) 2018; 97: e12359.","DOI":"10.1097\/MD.0000000000012359"},{"key":"5","unstructured":"5) WHO Classification of Tumours Editorial Board. WHO classification of tumours, 5th ed., Vol.1. Digestive system tumours. Geneva: World Health Organization; 2019."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 2022; 33: 115\u201354.","DOI":"10.1007\/s12022-022-09708-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Iwamoto S, Hara Y, Akabane A, et al. A Case of adenocarcinoma with enteroblastic differentiation at the esophagogastric junction (in Japanese). Nihon Shokaki Geka Gakkai Zasshi 2022; 55: 743\u20139.","DOI":"10.5833\/jjgs.2022.0020"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Motoyama T, Higuchi M, Taguchi J. Combined choriocarcinoma, hepatoid adenocarcinoma, small cell carcinoma and tubular adenocarcinoma in the oesophagus. Virchows Arch 1995; 427: 451\u20134.","DOI":"10.1007\/BF00199396"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Murakami T, Yao T, Mitomi H, et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differenciation: a study of 29 cases. Gastric Cancer 2016; 19: 498\u2013507.","DOI":"10.1007\/s10120-015-0497-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kawazoe T, Saeki H, Edahiro K, et al. A case of mixed adenoneuroendocrine carcinoma (MANEC) arising in Barrett\u2019s esophagus: literature and review. Surg Case Rep 2018; 4: 45.","DOI":"10.1186\/s40792-018-0454-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kinoshita T, Ishikawa S, Inaba T, et al. Neuroendocrine carcinoma arising from Barrett\u2019s esophageal adenocarcinoma: a case report. Clin J Gastroenterol 2020; 13: 1028\u201335.","DOI":"10.1007\/s12328-020-01210-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sugawara K, Fukuda T, Kishimoto Y, et al. Combined tubular adenocarcinoma, neuroendocrine carcinoma and adenocarcinoma with enteroblastic differentiation arising in Barrett esophagus. Clin J Gastroenterol 2023; 16: 501\u20137.","DOI":"10.1007\/s12328-023-01791-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 2008; 32: 1404\u201311.","DOI":"10.1097\/PAS.0b013e31816bf41f"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wang J, Liu W, Parikh K, et al. Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma. Clin J Gastroenterol 2017; 10: 7\u201312.","DOI":"10.1007\/s12328-016-0704-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sohda M, Kuwano H, Saeki H, et al. Nationwide survey of neuroendocrine carcinoma of the esophagus: a multicenter study conducted among institutions accredited by the Japan Esophageal Society. J Gastroenterol 2021; 56: 350\u20139.","DOI":"10.1007\/s00535-020-01756-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yamashita S, Abe H, Kunita A, et al. Programmed cell death protein 1\/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology 2021; 78: 381\u201391.","DOI":"10.1111\/his.14230"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.25-0619\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:04:33Z","timestamp":1771650273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.25-0619\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0619","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.25-0619"}}